Cheryl Cui, PhD
Board Member
Cheryle Cui is a Partner at Nest.Bio Ventures and CEO of Bota.
She was a former Venture Partner at VentureHealth, a Silicon Valley-based healthcare fund, where she coordinated portfolio companies’ growth strategy in the Asia Pacific. Cheryl previously co-founded a mobile health company that facilitates the care of Alzheimer’s patients, which was successfully acquired in 2012 and led to her selection as one of Canada’s Next 36. She currently serves as a Board Member of Rootpath and HiFiBio Therapeutics.
Cheryl earned her joint PhD degree in Medical Engineering and Medical Physics from MIT and Harvard Medical School and her B.A.Sc. in Engineering Science and Biomedical Engineer from the University of Toronto.